Endoluminal treatment for gastroesophageal reflux disease

Bonatti, 2008, Impact of changing epidemiology of gastroesophageal reflux disease on its diagnosis and treatment, J Gastrointest Surg, 12, 373, 10.1007/s11605-007-0294-9 Dent, 2009, Landmarks in the understanding and treatment of reflux disease, J Gastroenterol Hepatol, 24, S5, 10.1111/j.1440-1746.2009.06065.x Heidelbaugh, 2008, Atypical presentations of gastroesophageal reflux disease, Am Fam Physician, 78, 483 Labenz, 2010, Facts and fantasies in extra-oesophageal symptoms in GORD, Best Pract Res Clin Gastroenterol, 24, 893, 10.1016/j.bpg.2010.08.012 Auyang, 2013, SAGES Guidelines Committeee, SAGES clinical spotlight review: endoluminal treatments for gastroesophageal reflux disease (GERD), Surg Endosc, 27, 2658, 10.1007/s00464-013-3010-8 Heidelbaugh, 2009, Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk, Am J Gastroenterol, 104, S27, 10.1038/ajg.2009.49 Langevin, 2013, Gastric reflux is an independent risk factor for laryngopharyngeal carcinoma, Cancer Epidemiol Biomarkers Prev, 22, 1061, 10.1158/1055-9965.EPI-13-0183 Fass, 2010, Effect of gastroesophageal reflux disease on sleep, J Gastroenterol Hepatol, 25, S41, 10.1111/j.1440-1746.2009.06210.x Vakil, 2010, Disease definition, clinical manifestations, epidemiology and natural history of GERD, Best Pract Res Clin Gastroenterol, 24, 759, 10.1016/j.bpg.2010.09.009 El-Serag, 2014, Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review, Gut, 63, 871, 10.1136/gutjnl-2012-304269 Peery, 2012, Burden of gastrointestinal disease in the United States: 2012 update, Gastroenterology, 143, 1179, 10.1053/j.gastro.2012.08.002 Friedenberg, 2010, Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey, Dig Dis Sci, 55, 1911, 10.1007/s10620-009-1004-0 Brook, 2007, Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United States, Aliment Pharmacol Ther, 26, 889, 10.1111/j.1365-2036.2007.03428.x Pohle, 2000, Results of short-and long-term medical treatment of gastroesophageal reflux disease (GERD), Langenbecks Arch Surg, 385, 317, 10.1007/s004230000139 Quigley EMM, Heading RC, Monnikes H. Exploring the spectrum of GERD: myths and realities. Ann Gastroenterol 2007;20:155–63 Kahrilas, 2008, American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease, Gastroenterology, 135, 1383, 10.1053/j.gastro.2008.08.045 Katz, 2013, Guidelines for the diagnosis and management of gastroesophageal reflux disease, Am J Gastroenterol, 108, 308, 10.1038/ajg.2012.444 Forgacs, 2008, Overprescribing proton pump inhibitors, Br Med J, 336, 2, 10.1136/bmj.39406.449456.BE El-Serag, 2010, Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies, Aliment Pharmacol Ther, 32, 720, 10.1111/j.1365-2036.2010.04406.x Heidelbaugh, 2012, Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?, Int J Clin Pract, 66, 582, 10.1111/j.1742-1241.2012.02921.x Reavis, 2014, Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease, Expert Rev Med Devices, 11, 341, 10.1586/17434440.2014.925394 Perry, 2014, 2014 SSAT state-of-the-art conference: advances in diagnosis and management of gastroesophageal reflux disease, J Gastrointest Surg, 19, 458, 10.1007/s11605-014-2724-9 Lundell, 2007, Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis, Br J Surg, 94, 198, 10.1002/bjs.5492 Dallemagne, 2006, Clinical results of laparoscopic fundoplication at ten years after surgery, Surg Endosc, 20, 159, 10.1007/s00464-005-0174-x Locke, 2013, Endotherapy for and tailored approaches to treating GERD, and refractory GERD, Ann N Y Acad Sci, 1300, 166, 10.1111/nyas.12240 Triadafilopoulos, 2001, Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD, Gastrointest Endosc, 53, 407, 10.1067/mge.2001.112843 Wolfsen, 2002, The Stretta procedure for the treatment of GERD: a registry of 558 patients, J Laparoendosc Adv Surg Tech A, 12, 395, 10.1089/109264202762252640 Triadafilopoulos, 2002, The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial, Gastrointest Endosc, 55, 149, 10.1067/mge.2002.121227 Noar, 2007, Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure, Gastrointest Endosc, 65, 367, 10.1016/j.gie.2006.11.015 Arts, 2007, Influence of radiofrequency energy delivery at the gastroesophageal junction (the Stretta procedure) on symptoms, acid exposure, and esophageal sensitivity to acid perfusion in gastroesophagal reflux disease, Dig Dis Sci, 52, 2170, 10.1007/s10620-006-9695-y Franciosa, 2013, Stretta radiofrequency treatment for GERD: a safe and effective modality, Gastroenterol Res Pract, 2013, 783815, 10.1155/2013/783815 Meier, 2007, Improvement of objective GERD parameters after radiofrequency energy delivery: a European study, Scand J Gastroenterol, 42, 911, 10.1080/00365520601155191 Reymunde, 2007, Long-term results of radiofrequency energy delivery for the treatment of GERD: sustained improvements in symptoms, quality of life, and drug use at 4-year follow-up, Gastrointest Endosc, 65, 361, 10.1016/j.gie.2006.06.036 Go, 2004, Delivery of radiofrequency energy to the lower esophageal sphincter improves symptoms of gastroesophageal reflux, Surgery, 136, 786, 10.1016/j.surg.2004.07.006 Corley, 2003, Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial, Gastroenterology, 125, 668, 10.1016/S0016-5085(03)01052-7 Coron, 2008, Clinical trial: radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients, Aliment Pharmacol Ther, 28, 1147, 10.1111/j.1365-2036.2008.03790.x Aziz, 2010, A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease, Surg Endosc, 24, 818, 10.1007/s00464-009-0671-4 Arts, 2012, A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD, Am J Gastroenterol, 107, 222, 10.1038/ajg.2011.395 Perry, 2012, Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis, Surg Laparosc Endosc Percutan Tech, 22, 283, 10.1097/SLE.0b013e3182582e92 Dughera, 2011, Long-term results of radiofrequency energy delivery for the treatment of GERD: results of a prospective 48-month study, Diagn Ther Endosc, 2011, 507157, 10.1155/2011/507157 Noar, 2014, Long-term maintenance effect of radiofrequency energy delivery for refractory GERD: a decade later, Surg Endosc, 28, 2323, 10.1007/s00464-014-3461-6 Cadière, 2006, Endoluminal fundoplication (ELF)—evolution of EsophyX, a new surgical device for transoral surgery, Minim Invasive Ther Allied Technol, 15, 348, 10.1080/13645700601040024 Jobe, 2008, Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device, Ann Surg, 248, 69, 10.1097/SLA.0b013e31817c9630 Cadière, 2008, Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study, World J Surg, 32, 1676, 10.1007/s00268-008-9594-9 Cadière, 2009, Two-year results of a feasibility study on antireflux transoral incisionless fundoplication using EsophyX, Surg Endosc, 23, 957, 10.1007/s00464-009-0384-8 Demyttenaere, 2010, Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population, Surg Endosc, 24, 854, 10.1007/s00464-009-0676-z Testoni, 2010, Effect of transoral incisionless fundoplication on symptoms, PPI use, and ph-impedance refluxes of GERD patients, World J Surg, 34, 750, 10.1007/s00268-010-0394-7 Bell, 2011, Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease, Surg Endosc, 25, 1975, 10.1007/s00464-010-1497-9 Trad, 2012, Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms, Surg Endosc, 26, 650, 10.1007/s00464-011-1932-6 Petersen, 2012, Comprehensive evaluation of endoscopic fundoplication using the EsophyX™ device, Surg Endosc, 26, 1021, 10.1007/s00464-011-1989-2 Barnes, 2011, Transoral incisionless fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice, Surg Innov, 18, 119, 10.1177/1553350610392067 Bell, 2012, A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication, J Am Coll Surg, 215, 794, 10.1016/j.jamcollsurg.2012.07.014 Hoppo, 2010, Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease, J Gastrointest Surg, 14, 1895, 10.1007/s11605-010-1331-7 Frazzoni, 2011, Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD, Aliment Pharmacol Ther, 34, 67, 10.1111/j.1365-2036.2011.04677.x Trad, 2015, Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial, Surg Innov, 22, 26, 10.1177/1553350614526788 Hunter, 2015, Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial, Gastroenterology, 148, 324, 10.1053/j.gastro.2014.10.009 Wendling, 2013, Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature, Surg Endosc, 27, 3754, 10.1007/s00464-013-2961-0 Testoni, 2012, Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome, Surg Endosc, 26, 1425, 10.1007/s00464-011-2050-1 Witteman, 2012, Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice, Surg Endosc, 26, 3307, 10.1007/s00464-012-2324-2 Muls, 2013, Three-year results of a multicenter prospective study of transoral incisionless fundoplication, Surg Innov, 20, 321, 10.1177/1553350612459275 Kauer, 2009, Preclinical trial of a modified gastroscope that performs a true anterior fundoplication for the endoluminal treatment of gastroesophageal reflux disease, Surg Endosc, 23, 2728, 10.1007/s00464-009-0479-2 Danalioglu, 2014, Endoscopic stapling in comparison to laparoscopic fundoplication for the treatment of gastroesophageal reflux disease, Dig Endosc, 26, 37, 10.1111/den.12081 Zacherl, 2015, Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial, Surg Endosc, 29, 220, 10.1007/s00464-014-3731-3 Triadafilopoulos, 2003, Stretta: an effective, minimally invasive treatment for gastroesophageal reflux disease, Am J Med, 115, 192S, 10.1016/S0002-9343(03)00224-9 Funk, 2015, Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease, Surgery, 157, 126, 10.1016/j.surg.2014.05.027